Angwin, Catherine https://orcid.org/0000-0002-0935-5284
Jenkinson, Caroline
Jones, Angus https://orcid.org/0000-0002-0883-7599
Jennison, Christopher
Henley, William
Farmer, Andrew https://orcid.org/0000-0002-6170-4402
Sattar, Naveed https://orcid.org/0000-0002-1604-2593
Holman, Rury R
Pearson, Ewan
Shields, Beverley https://orcid.org/0000-0003-3785-327X
Hattersley, Andrew
Clinical trials referenced in this document:
Documents that mention this clinical trial
Precision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of Treatment
https://doi.org/10.2337/dbi20-0002
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol (Pre-results)
https://doi.org/10.1136/bmjopen-2020-042784
Funding for this research was provided by:
Medical Research Council (MR/N00633X/1)